@article{b6b070df17f04bc1a194afc948c744f4,
title = "Addressing and communicating heterogeneous treatment effects for patient subpopulations: Challenges and opportunities",
author = "Ravi Varadhan",
note = "Funding Information: This work was supported by a Center of Excellence in Regulatory Science and Innovation (CERSI) grant to Johns Hopkins University from the US Food & Drug Administration (U01FD005942). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the HHS or FDA. Funding Information: This work was supported by a Center of Excellence in Regulatory Science and Innovation (CERSI) grant to Johns Hopkins University from the US Food & Drug Administration (U01FD005942). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the HHS or FDA.",
year = "2021",
month = sep,
day = "1",
doi = "10.1002/pst.2164",
language = "English (US)",
volume = "20",
pages = "920--922",
journal = "Pharmaceutical Statistics",
issn = "1539-1604",
publisher = "John Wiley and Sons Ltd",
number = "5",
}